Evox Therapeutics (NASDAQ:EVOXW) Stock Price Down 12% – Time to Sell?

Evox Therapeutics plc (NASDAQ:EVOXW)’s share price was down 12% during trading on Thursday . The company traded as low as $0.34 and last traded at $0.3698. Approximately 9,712 shares were traded during mid-day trading, a decline of 72% from the average session volume of 34,266 shares. The stock had previously closed at $0.42.

Evox Therapeutics Trading Up 0.3%

The company has a 50-day moving average price of $0.39 and a two-hundred day moving average price of $0.40.

Evox Therapeutics plc is a biotechnology company developing therapeutics built on engineered extracellular vesicles (EVs), commonly referred to as exosomes, designed to deliver a broad range of therapeutic payloads. The company’s platform focuses on using naturally occurring nanoscale vesicles as vehicles to carry biologics—such as RNA, proteins and other macromolecules—into target cells and tissues. Evox aims to leverage the innate properties of EVs for targeted delivery, biodistribution and reduced immunogenicity compared with some synthetic delivery systems.

The company’s research and development activities center on engineering EVs for tissue-specific targeting and intracellular delivery, with the goal of addressing diseases that are difficult to treat with conventional approaches, including disorders of the central nervous system and certain rare genetic conditions.